Gene ontology annotations for FYN |
|
Experiment description of studies that identified FYN in exosomes |
1 |
Experiment ID |
207 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101|HSP70
|
EV Cytosolic markers |
✔
FLOT1
|
EV Membrane markers |
✔
VDAC
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ. |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
DKO-1 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
2 |
Experiment ID |
208 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101|HSP70
|
EV Cytosolic markers |
✔
FLOT1
|
EV Membrane markers |
✔
VDAC
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ. |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
Dks-8 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
3 |
Experiment ID |
209 |
ISEV standards |
✘
|
EV Biophysical techniques |
✔
TSG101|HSP70
|
EV Cytosolic markers |
✔
FLOT1
|
EV Membrane markers |
✔
VDAC
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ. |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
DLD-1 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
4 |
Experiment ID |
254 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101
|
EV Cytosolic markers |
✔
FLOT1|CD81
|
EV Membrane markers |
✘
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
MNT-1 |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
5 |
Experiment ID |
255 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101
|
EV Cytosolic markers |
✔
FLOT1
|
EV Membrane markers |
✘
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
G1 |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
6 |
Experiment ID |
256 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101
|
EV Cytosolic markers |
✔
FLOT1
|
EV Membrane markers |
✘
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
501mel |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
7 |
Experiment ID |
257 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101
|
EV Cytosolic markers |
✔
FLOT1
|
EV Membrane markers |
✘
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
Daju |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
8 |
Experiment ID |
258 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101
|
EV Cytosolic markers |
✔
FLOT1|CD81
|
EV Membrane markers |
✘
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
SKMEL28 |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
9 |
Experiment ID |
259 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101
|
EV Cytosolic markers |
✔
FLOT1
|
EV Membrane markers |
✘
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
A375M |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
10 |
Experiment ID |
260 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101
|
EV Cytosolic markers |
✔
FLOT1|CD81
|
EV Membrane markers |
✘
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
1205Lu |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
11 |
Experiment ID |
224 |
ISEV standards |
✔
EM|AFM
|
EV Biophysical techniques |
✔
Alix|TSG101
|
EV Cytosolic markers |
✔
CD63|CD81
|
EV Membrane markers |
✔
GOLGA2
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25944692
|
Organism |
Homo sapiens |
Experiment description |
Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes |
Authors |
Keerthikumar S, Gangoda L, Liem M, Fonseka P, Atukorala I, Ozcitti C, Mechler A, Adda CG, Ang CS, Mathivanan S |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Neuroblastoma cells |
Sample name |
SH-SY5Y |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation OptiPrep density gradient |
Flotation density |
1.10 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Western blotting |
|
|
12 |
Experiment ID |
231 |
ISEV standards |
✘
|
EV Biophysical techniques |
✔
Alix
|
EV Cytosolic markers |
✔
CD63|CD9
|
EV Membrane markers |
✘
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G. |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 1 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein Lipids |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
13 |
Experiment ID |
232 |
ISEV standards |
✘
|
EV Biophysical techniques |
✘
|
EV Cytosolic markers |
✘
|
EV Membrane markers |
✘
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G. |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
14 |
Experiment ID |
233 |
ISEV standards |
✘
|
EV Biophysical techniques |
✘
|
EV Cytosolic markers |
✘
|
EV Membrane markers |
✘
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G. |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 3 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
15 |
Experiment ID |
274 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101|Alix|RAB5A
|
EV Cytosolic markers |
✔
CD9|CD82|CD63|CD81
|
EV Membrane markers |
✔
AIF
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25844599
|
Organism |
Homo sapiens |
Experiment description |
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
Authors |
Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T. |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Prostate cancer cells |
Sample name |
DU145 - Docetaxel resistant |
Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.18 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Flow cytometry Western blotting |
|
|
16 |
Experiment ID |
217 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
TSG101
|
EV Cytosolic markers |
✔
CD81|CD9|CD63
|
EV Membrane markers |
✘
|
EV Negative markers |
✔
NTA
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23844026
|
Organism |
Homo sapiens |
Experiment description |
Characterization of human thymic exosomes. |
Authors |
Skogberg G, Gudmundsdottir J, van der Post S, Sandstrom K, Bruhn S, Benson M, Mincheva-Nilsson L, Baranov V, Telemo E, Ekwall O. |
Journal name |
PLoS One
|
Publication year |
2013 |
Sample |
Thymus |
Sample name |
Normal-Thymus |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
17 |
Experiment ID |
196 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
Alix|TSG101|HSP70
|
EV Cytosolic markers |
✔
CD9
|
EV Membrane markers |
✘
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
22418980
|
Organism |
Homo sapiens |
Experiment description |
A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes. |
Authors |
Raj DA, Fiume I, Capasso G, Pocsfalvi G. |
Journal name |
Kidney Int
|
Publication year |
2012 |
Sample |
Urine |
Sample name |
Urine - Normal high density |
Isolation/purification methods |
Differential centrifugation Sucrose cushion |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
18 |
Experiment ID |
197 |
ISEV standards |
✔
EM
|
EV Biophysical techniques |
✔
Alix|TSG101|HSP70
|
EV Cytosolic markers |
✔
CD9
|
EV Membrane markers |
✘
|
EV Negative markers |
✘
|
EV Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
22418980
|
Organism |
Homo sapiens |
Experiment description |
A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes. |
Authors |
Raj DA, Fiume I, Capasso G, Pocsfalvi G. |
Journal name |
Kidney Int
|
Publication year |
2012 |
Sample |
Urine |
Sample name |
Urine - Normal low density |
Isolation/purification methods |
Differential centrifugation Sucrose cushion |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
Protein-protein interactions for FYN |
|
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
1 |
CD48 |
962 |
Invitro |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
2 |
CSK |
1445 |
Affinity Capture-Western |
|
Homo sapiens |
|
3 |
DAG1 |
1605 |
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
4 |
CD2AP |
23607 |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
|
5 |
SOCS1 |
|
Reconstituted Complex |
|
Homo sapiens |
|
6 |
GRB10 |
2887 |
Biochemical Activity |
|
Homo sapiens |
|
7 |
EVL |
51466 |
Affinity Capture-MS |
|
Homo sapiens |
|
8 |
CD247 |
919 |
Affinity Capture-MS |
|
Homo sapiens |
|
9 |
EPHA8 |
|
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
10 |
CD2 |
914 |
Affinity Capture-MS |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
11 |
WAS |
7454 |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Invivo |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
12 |
PLCG2 |
5336 |
Affinity Capture-MS |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
13 |
ARHGAP32 |
|
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
14 |
PDGFRB |
5159 |
Affinity Capture-MS |
|
Homo sapiens |
|
15 |
ZAP70 |
7535 |
Phenotypic Enhancement |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
16 |
YES1 |
7525 |
Affinity Capture-Western |
|
Homo sapiens |
|
17 |
SRC |
6714 |
Protein-peptide |
|
Homo sapiens |
|
18 |
KHDRBS1 |
10657 |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
19 |
SYK |
6850 |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
20 |
YT521 |
|
Biochemical Activity |
|
Homo sapiens |
|
21 |
TUBA3C |
7278 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
22 |
CDK1 |
983 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
23 |
CD44 |
960 |
Invitro |
|
Homo sapiens |
Invivo |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
24 |
NMT1 |
4836 |
Biochemical Activity |
|
Homo sapiens |
|
25 |
MCAM |
4162 |
Affinity Capture-Western |
|
Homo sapiens |
|
26 |
TRPV4 |
59341 |
Invitro |
|
Homo sapiens |
Invivo |
|
Homo sapiens |
|
27 |
FAS |
355 |
Affinity Capture-MS |
|
Homo sapiens |
Invivo |
|
Homo sapiens |
|
28 |
MAG |
|
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
|
29 |
NEDD9 |
4739 |
Affinity Capture-Western |
|
Homo sapiens |
|
30 |
PLAUR |
5329 |
Invitro |
|
Homo sapiens |
Invivo |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
31 |
FASLG |
356 |
Invitro |
|
Homo sapiens |
|
32 |
VAV1 |
7409 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
33 |
UNC119 |
|
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
34 |
SKAP1 |
8631 |
Reconstituted Complex |
|
Homo sapiens |
|
35 |
NPHS1 |
4868 |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Biochemical Activity |
|
Homo sapiens |
|
36 |
SKAP2 |
8935 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
37 |
CBL |
867 |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
38 |
ADD2 |
119 |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
39 |
MAPT |
|
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
40 |
CDH1 |
999 |
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
41 |
TUBA1B |
10376 |
Affinity Capture-MS |
|
Homo sapiens |
|
42 |
FYN |
2534 |
Invitro |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
43 |
TYK2 |
7297 |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
44 |
PTK2B |
2185 |
Affinity Capture-Western |
|
Homo sapiens |
Invivo |
|
Homo sapiens |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
|
45 |
CNTN1 |
1272 |
Invivo |
|
Homo sapiens |
|
46 |
PIK3R2 |
|
Reconstituted Complex |
|
Homo sapiens |
Biochemical Activity |
|
Homo sapiens |
|
47 |
PIK3R1 |
5295 |
Reconstituted Complex |
|
Homo sapiens |
|
48 |
BTK |
695 |
Reconstituted Complex |
|
Homo sapiens |
|
49 |
GRIN2A |
|
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
50 |
SH3BP2 |
|
Two-hybrid |
|
Homo sapiens |
|
51 |
SOS1 |
|
Invitro |
|
Homo sapiens |
|
52 |
PECAM1 |
5175 |
Affinity Capture-Western |
|
Homo sapiens |
|
53 |
SH2D1A |
4068 |
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
54 |
PTPN11 |
5781 |
Invitro |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
55 |
SDC3 |
|
Invitro |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
56 |
Mta3 |
|
Reconstituted Complex |
|
Mus musculus |
|
57 |
DLG4 |
|
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
58 |
CTNNB1 |
1499 |
Biochemical Activity |
|
Homo sapiens |
|
59 |
PTPRA |
5786 |
Invivo |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
60 |
CHRNA7 |
|
Affinity Capture-Western |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
61 |
PTK2 |
5747 |
Invitro |
|
Homo sapiens |
|
62 |
CD226 |
10666 |
Invivo |
|
Homo sapiens |
|
63 |
TUBA4A |
7277 |
Affinity Capture-MS |
|
Homo sapiens |
|
64 |
PRKCQ |
5588 |
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Biochemical Activity |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Biochemical Activity |
|
Homo sapiens |
|
65 |
IL7R |
|
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
|
66 |
BCL3 |
|
Invivo |
|
Homo sapiens |
|
67 |
GRIN2B |
|
Invitro |
|
Homo sapiens |
|
68 |
RAF1 |
5894 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
69 |
SIT1 |
27240 |
Invivo |
|
Homo sapiens |
|
70 |
TRPC6 |
7225 |
Affinity Capture-Western |
|
Homo sapiens |
Biochemical Activity |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
71 |
CD55 |
1604 |
Affinity Capture-MS |
|
Homo sapiens |
|
72 |
EPHB3 |
2049 |
Reconstituted Complex |
|
Homo sapiens |
|
73 |
CSF1R |
|
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
74 |
THY1 |
7070 |
Invivo |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
75 |
ITK |
3702 |
Invivo |
|
Homo sapiens |
Invitro |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
76 |
CBLC |
|
Affinity Capture-Western |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
77 |
SNCA |
6622 |
Biochemical Activity |
|
Homo sapiens |
|
78 |
FNBP4 |
|
Invitro |
|
Homo sapiens |
Affinity Capture-MS |
|
| | | |